Similar articles for PMID: 31998296

Year	Number of Results
1991	1
1998	1
2000	2
2001	3
2003	2
2004	2
2005	1
2006	3
2007	4
2008	6
2009	17
2010	7
2011	16
2012	14
2013	13
2014	16
2015	19
2016	22
2017	8
2018	16
2019	12
2020	47
2021	34
2022	24
2023	11
2024	1

1

Tolerating Factor VIII: Recent Progress.

Lacroix-Desmazes S, Voorberg J, Lillicrap D, Scott DW, Pratt KP. Lacroix-Desmazes S, et al. Front Immunol. 2020 Jan 10;10:2991. doi: 10.3389/fimmu.2019.02991. eCollection 2019. Front Immunol. 2020. PMID: 31998296 Free PMC article. Review.

2

Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16.

Lagassé HAD, Hopkins LB, Jankowski W, Jacquemin MG, Sauna ZE, Golding B. Lagassé HAD, et al. Front Immunol. 2021 Jun 28;12:692157. doi: 10.3389/fimmu.2021.692157. eCollection 2021. Front Immunol. 2021. PMID: 34262568 Free PMC article.

3

To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.

Hartholt RB, van Velzen AS, Peyron I, Ten Brinke A, Fijnvandraat K, Voorberg J. Hartholt RB, et al. Blood Rev. 2017 Sep;31(5):339-347. doi: 10.1016/j.blre.2017.07.001. Epub 2017 Jul 4. Blood Rev. 2017. PMID: 28716211 Review.

4

Inhibitory antibodies in hemophilia A.

Pratt KP. Pratt KP. Curr Opin Hematol. 2012 Sep;19(5):399-405. doi: 10.1097/MOH.0b013e328356ed37. Curr Opin Hematol. 2012. PMID: 22814650 Review.

5

Innovating immune tolerance induction for haemophilia.

Batsuli G, Meeks SL, Herzog RW, Lacroix-Desmazes S. Batsuli G, et al. Haemophilia. 2016 Jul;22 Suppl 5:31-5. doi: 10.1111/hae.12989. Haemophilia. 2016. PMID: 27405673 Review.

6

Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice.

Krishnamoorthy S, Liu T, Drager D, Patarroyo-White S, Chhabra ES, Peters R, Josephson N, Lillicrap D, Blumberg RS, Pierce GF, Jiang H. Krishnamoorthy S, et al. Cell Immunol. 2016 Mar;301:30-9. doi: 10.1016/j.cellimm.2015.12.008. Epub 2015 Dec 29. Cell Immunol. 2016. PMID: 26775174 Free PMC article.

7

Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII Antibodies.

Lacroix-Desmazes S, Pratt KP. Lacroix-Desmazes S, et al. Front Immunol. 2021 Jan 25;11:639386. doi: 10.3389/fimmu.2020.639386. eCollection 2020. Front Immunol. 2021. PMID: 33569066 Free PMC article. No abstract available.

8

Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization.

Kis-Toth K, Rajani GM, Simpson A, Henry KL, Dumont J, Peters RT, Salas J, Loh C. Kis-Toth K, et al. Blood Adv. 2018 Nov 13;2(21):2904-2916. doi: 10.1182/bloodadvances.2018024497. Blood Adv. 2018. PMID: 30396910 Free PMC article.

9

Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis.

Miners AH, Krishnan S, Pasi KJ. Miners AH, et al. J Thromb Haemost. 2016 Nov;14(11):2141-2147. doi: 10.1111/jth.13440. Epub 2016 Oct 3. J Thromb Haemost. 2016. PMID: 27510890 Free article.

10

Progress toward inducing immunologic tolerance to factor VIII.

Scott DW, Pratt KP, Miao CH. Scott DW, et al. Blood. 2013 May 30;121(22):4449-56. doi: 10.1182/blood-2013-01-478669. Epub 2013 Mar 15. Blood. 2013. PMID: 23502223 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

261 results

Results by year